Nonprofit Pharma Targets Making Naloxone Available OTC, Trimming Price
This article was originally published in The Pink Sheet
Executive Summary
Nonprofit Harm Reduction Therapeutics targets an OTC switch of naloxone, an opioid antagonist used to reverse an opioid overdose. It aims to make the product available at low cost in 110,000 retail locations nationwide.